Table 2.
Baseline echocardiographic characteristics of the RSVB population and comparison with controls.
| Variable | RSVB Group (n = 50) | Control Group (n = 50) | p Value |
|---|---|---|---|
| Pericardial effusion | 17 (34) | 3 (6) | <0.001 |
| Left ventricle | |||
| LVDD (mm) | 21 (17–29) | 21 (14–28) | 0.470 |
| LVSF (%) | 38.5 (5.6) | 39 (5) | 0.851 |
| Sm (cm/s) | 8.7 (1.6) | 9 (1.2) | 0.573 |
| Mitral E (cm/s) | 98 (79–125) | 96 (76–123) | 0.798 |
| Mitral A (cm/s) | 75 (49–97) | 71 (51–93) | 0.259 |
| Mitral E/A | 1.25 (0.93–1.98) | 1.43 (1–2) | 0.200 |
| Mitral Em (cm/s) | 9.4 (6–5–14) | 10 (6.6–15) | 0.110 |
| Mitral Am (cm/s) | 9 (5–15) | 9 (6–13) | 0.182 |
| Mitral E/Em (cm/s) | 10.2 (5.8–20) | 9.8 (5.2–17) | 0.283 |
| LVTX | 0.42 (0.25–0.65) | 0.36 (0.26–0.47) | 0.008 |
| Right ventricle | |||
| RVDD (mm) | 10 (7–19) | 10 (7–14) | 0.264 |
| RV/LV ratio | 0.49 (0.28–0.80) | 0.46 (0.28–0.76) | 0.473 |
| TAPSE (mm) | 12.3 (1.6) | 12 (1.8) | 0.624 |
| St (cm/s) | 8.5 (2) | 9.1 (1.7) | 0.901 |
| RVTX | 0.39 (0.25–0.65) | 0.37 (0.26–0.48) | 0.005 |
| Adequate TRJ | 25 (50) | 30 (60) | 0.633 |
| TRJG (mmHg) | 27 (18–47) | 22 (16–34) | 0.013 |
| ATET | 0.38 (0.06) | 0.39 (0.03) | 0.288 |
| LVEI | 1.08 (0.98–1.45) | 1 (0.95–1.12) | <0.001 |
| Septal Flattening | 14 (28) | 3 (6) | 0.003 |
LVDD (left ventricle diastolic diameter); LVSF (left ventricular shortening fraction); LVTX (left ventricular Tei index); RVDD (right ventricular diastolic diameter); RV (right ventricle); LV (Left ventricle); TAPSE (tricuspid annular plane systolic excursion); RVTX (Right ventricular Tei index), TRJ (tricuspid regurgitation jet); TRJG (tricuspid regurgitation jet gradient); ATET (right ventricular acceleration time/right ventricular ejection time ratio); LVEI (systolic left ventricular eccentricity index).